Cypriot AI Breast Cancer Startup MammoCheck Raises €500K, Eyes US/Europe Expansion

MammoCheck, a Cypriot healthtech firm, secured €500,000 from the SEED Program and is raising an additional €1 million to expand its AI-based breast cancer screening into the US and Europe. The funding is modest and the expansion is early-stage, but it signals growing commercial traction for AI diagnostics in oncology.